|
16-Epidesacetylfusidic acid
|
夫西地酸鈉EP雜質(zhì)I
|
5951-83-7
|
|
Fusidic Acid Impurity J(EP)
|
夫西地酸鈉EP雜質(zhì)J
|
13011-12-6
|
|
16-O-deacetylfusidic acid lactone
|
夫西地酸鈉EP雜質(zhì)K
|
4701-54-6
|
|
Fusidic Acid BP Impurity L
|
夫西地酸鈉EP雜質(zhì)L
|
74048-41-2
|
|
Sodium Fusidate EP Impurity C
|
夫西地酸鈉EP雜質(zhì)C
|
|
|
27-Oxo-fusidic Acid
|
夫西地酸鈉EP雜質(zhì)F
|
1415035-94-7
|
|
3-KETOFUSIDIC ACID
|
夫西地酸鈉EP雜質(zhì)G
|
4680-37-9
|
|
11-monoketofusidic acid
|
夫西地酸鈉EP雜質(zhì)H
|
16711-91-4
|
|
(3α,4α,8α,9β,13α,14β,16β,17Z)-16-(Acetyloxy)-3-hydroxy-29-nordaMMara-17(20),24-dien-21-oic Acid
|
夫西地酸鈉EP雜質(zhì)M
|
1013937-16-0
|
|
16-O-deacetylfusidic acid
|
夫西地酸鈉EP雜質(zhì)O
|
13090-91-0
|
|
Glycine, N-methyl-, [2-(methylamino)-3-pyridinyl]methyl ester
|
艾沙康唑雜質(zhì)BAL20019
|
2732924-98-8
|
|
Isavuconazole Impurity
|
艾莎康唑雜質(zhì)BAL19717
|
21661-87-0
|
|
Isavuconazole
|
艾莎康唑
|
241479-67-4
|
|
2-(Methylamino)pyridine-3-methanol
|
艾沙康唑雜質(zhì)BAL17701
|
32399-12-5
|
|
NA
|
艾莎康唑硫酸鹽RS異構(gòu)體
|
|
|
NA
|
艾莎康唑RS 異構(gòu)體
|
|
|
NA
|
氰基SR異構(gòu)體
|
|
|
NA
|
氰基RS異構(gòu)體
|
|
|
Methyldopa
|
甲基多巴
|
555-30-6
|
|
α-Methyl-3,4-dihydroxy-L-phenylalanine methyl ester
|
卡比多巴EP 雜質(zhì)B
|
18181-08-3
|
|
(S)-2-hydrazino-3-(4-hydroxy-3-methoxyphenyl)-2-methylpropionic acid
|
卡比多巴雜質(zhì)C
|
84488-77-7
|
|
Carbidopa impurity D
|
卡比多巴雜質(zhì)D
|
934371-48-9
|
|
Carbidopa impurity E
|
卡比多巴雜質(zhì)E
|
52514-63-3
|
|
Carbidopa impurity F
|
卡比多巴雜質(zhì)F
|
1458640-32-8
|
|
3,4-dihydroxyphenylacetone
|
卡比多巴雜質(zhì)G
|
2503-44-8
|
|
Carbidopa Impurity 2
|
卡比多巴雜質(zhì)H
|
1361017-74-4
|
|
3-Bromo Carbidopa
|
卡比多巴雜質(zhì)I
|
1246819-09-9
|
|
2-Bromo (S)-Carbidopa
|
卡比多巴雜質(zhì)J
|
43197-33-7
|
|
MK 485
|
R-(+)-卡比多巴
|
28875-92-5
|
|
NA
|
卡非佐米雜質(zhì)D1
|
|
|
Carfilzomib Impurity 15
|
卡非佐米雜質(zhì)5
|
1541171-67-8
|
|
Carfilzomib Impurity 4 (N-Oxide Impurity)
|
卡非佐米雜質(zhì)6
|
1672698-96-2
|
|
Carfilzomib Impurity D3
|
卡非佐米雜質(zhì)D3
|
|
|
Carfilzomib Impurity D4
|
卡非佐米雜質(zhì)D4
|
|
|
Carfilzomib Impurity 2
|
卡非佐米雜質(zhì)9
|
1541172-75-1
|
|
Carfilzomib Impurity 36
|
卡非佐米雜質(zhì)12
|
2049023-89-2
|
|
(S)-N-((S)-1-(((S)-2,6-Dimethyl-3-oxohept-1-en-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide
|
卡非佐米雜質(zhì)17
|
1660143-42-9
|
|
(S)-4-Methyl-N-((S)-1-(((S)-4-Methyl-1-((S)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide
|
卡非佐米雜質(zhì)13
|
1672698-88-2
|
|
(S)-4-Methyl-N-((S)-1-(((R)-4-Methyl-1-((S)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide
|
卡非佐米雜質(zhì)14
|
2049025-67-2
|
|
(S)-4-Methyl-N-((S)-1-(((R)-4-Methyl-1-((R)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide
|
卡非佐米雜質(zhì)15
|
2049025-76-3
|
|
(R)-4-Methyl-N-((S)-1-(((S)-4-Methyl-1-((R)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide
|
卡非佐米雜質(zhì)34
|
2049025-45-6
|
|
(6R,9S,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate
|
卡非佐米雜質(zhì)18
|
2049024-37-3
|
|
(alphaS)-alpha-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-L-phenylalanine methyl ester
|
卡非佐米雜質(zhì)36
|
1140908-89-9
|
|
(S)-2-((S)-2-Acetamido-4-phenylbutanamido)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)pentanamide
|
卡非佐米雜質(zhì)20
|
254888-42-1
|
|
(S)-4-Methyl-N-((R)-1-(((S)-4-Methyl-1-((R)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide
|
卡非佐米雜質(zhì)22
|
2049025-49-0
|
|
(S)-2-((S)-4-Methyl-2-((R)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid
|
卡非佐米雜質(zhì)35
|
2049024-77-1
|
|
Carfilzomib Impurity 52
|
卡非佐米雜質(zhì)24
|
2049024-27-1
|
|
(S)-benzyl 2-((S)-2-(tert-butoxycarbonylamino)-4-methylpentanamido)-3-phenylpropanoate
|
卡非佐米雜質(zhì)25
|
70637-26-2
|
|
(S)-benzyl 2-((S)-2-amino-4-methylpentanamido)-3-phenylpropanoate hydrochloride
|
卡非佐米雜質(zhì)26
|
70691-56-4
|
|
Carfilzomib Impurity 34
|
卡非佐米雜質(zhì)27
|
2381627-87-6
|
|
CarbaMic acid, N-[(1S)-3-Methyl-1-[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-diMethylethyl ester
|
卡非佐米雜質(zhì)28
|
247068-82-2
|
|
Carfilzomib Impurity 35
|
卡非佐米雜質(zhì)29
|
2177287-68-0
|
|
Carfilzomib Impurity 65
|
卡非佐米雜質(zhì)30
|
2177287-70-4
|
|
(alphaS)-alpha-[(4-Morpholinylacetyl)aMino]benzenebutanoyl-L-leucyl-L-phenylalanine
|
卡非佐米雜質(zhì)31
|
868540-16-3
|
|
CarbaMic acid, N-[(1S)-3-Methyl-1-[[(2S)-2-Methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-diMethylethyl ester
|
卡非佐米雜質(zhì)32
|
247068-83-3
|
|
CarbaMic acid, [(1S)-3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl ester (9CI)
|
卡非佐米雜質(zhì)33
|
247068-81-1
|
|
Carfilzomib
|
卡非佐米
|
868540-17-4
|
|
Lemborexant
|
萊博雷生雜質(zhì)1
|
1369764-02-2
|
|
(1S,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide
|
萊博雷生差向異構(gòu)體1
|
|
|
Nalmefene hydrochloride
|
鹽酸納美芬
|
58895-64-0
|
|
NalMefene IMpurity
|
納美芬雜質(zhì)1
|
91598-83-3
|
|
Naffine impurity 2
|
納美芬雜質(zhì)2
|
|
|
Nalmefene Impurity 3
|
納美芬雜質(zhì)3
|
|
|
Dihydroxy Melphatalan
|
美法侖EP雜質(zhì)A
|
72143-20-5
|
|
Melphalan Impurity B
|
美法侖EP雜質(zhì)B
|
1270153-04-2
|
|
Melphalan Mono-chloroethyl Impurity
|
美法侖EP雜質(zhì)C
|
573704-41-3
|
|
Hydroxymelphalan
|
美法侖EP雜質(zhì)D
|
61733-01-5
|
|
L-Phenylalanine, 4-[bis(2-chloroethyl)amino]-3-chloro-, hydrochloride (1:1)
|
美法侖EP雜質(zhì)F
|
2724878-98-0
|
|
Melphalan Dimer Hydrochloride
|
美法侖EP雜質(zhì)G
|
2238824-44-5
|
|
Melphalan Methyl Ester HCl
|
美法侖EP雜質(zhì)I
|
62978-52-3
|
|
L-Phenylalanine, 4-[[2-(2-chloroethoxy)ethyl](2-chloroethyl)amino]-
|
美法侖EP雜質(zhì)J
|
2724549-95-3
|
|
NSC 35051
|
美法侖D-異構(gòu)體
|
13045-94-8
|
|
1-(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) (16-(tert-butoxy)-16-oxohexadecanoyl)-L-glutamate
|
德谷胰島素雜質(zhì)1
|
843666-26-2
|
|
L-Glutamic acid 5-tert-butyl ester
|
德谷胰島素雜質(zhì)2
|
2419-56-9
|
|
L-GlutaMic acid, 1-(1,1-diMethylethyl) 5-(phenylMethyl) ester
|
德谷胰島素雜質(zhì)3
|
80165-23-7
|
|
NA
|
德谷胰島素雜質(zhì)4
|
|
|
gamma-Benzyl L-glutamate
|
德谷胰島素雜質(zhì)5
|
1676-73-9
|
|
Deglutathin impurity 6
|
德谷胰島素雜質(zhì)6
|
|
|
Deglutathin impurity 7
|
德谷胰島素雜質(zhì)7
|
|
|
Deglutathin impurity 8
|
德谷胰島素雜質(zhì)8
|
|
|
Deglutathin impurity 10
|
德谷胰島素雜質(zhì)10
|
|
|
Deglutathin impurity 11
|
德谷胰島素雜質(zhì)11
|
|
|
Carfilzomib Impurity D2
|
卡非佐米雜質(zhì)D2
|
|
|
(S)-N-((S)-1-(((2R,4S)-1-((1H-Benzo[d][1,2,3]triazol-1-yl)oxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide
|
卡非佐米雜質(zhì)2
|
1541171-68-9
|
|
CarfilzoMib IMpurity 3
|
卡非佐米雜質(zhì)3
|
|
|
NA
|
艾莎康唑SR 異構(gòu)體
|
|
|
Deglutathin impurity 9
|
德谷胰島素雜質(zhì)9
|
|
|
NA
|
美法侖EP雜質(zhì)E
|
|
|
(1R,2R)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide
|
萊博雷生差向異構(gòu)體2
|
|
|
(1S,2R)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide
|
萊博雷生對(duì)映異構(gòu)體
|
|
|
Benzenepropanoic acid, 3,4-dihydroxy-α-methyl-α-[2-(1-methylethyl)diazenyl]-, methyl ester, (αS)-
|
卡比多巴丙酮亞胺酯雜質(zhì)
|
1402053-59-1
|
|
NA
|
氰基SS異構(gòu)體
|
|
|
NA
|
艾莎康唑SS 異構(gòu)體
|
|
|
NA
|
艾莎康唑硫酸鹽SS異構(gòu)體
|
|
|
Isaconazole impurity BAL107551
|
艾莎康唑雜質(zhì)BAL107551
|
|
|
Isaconazole impurity BAL107767
|
艾莎康唑雜質(zhì)BAL107767
|
|
|
NA
|
艾莎康唑雜質(zhì)BAL31264
|
|
|
2H-Pyrido[2,3-d][1,3]oxazin-2-one, 1,4-dihydro-1-methyl-
|
艾沙康唑雜質(zhì)BAL8728
|
2734004-61-4
|
|
NA
|
夫西地酸鈉EP雜質(zhì)E
|
|
|
Sodium Fusidate EP Impurity D
|
夫西地酸鈉EP雜質(zhì)D
|
|